ArticleNeurology and therapy2016

Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.

Ralf A Linker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.